J&J’s Floyd Says Hip Sales Halted for Business Reasons

The former president of Johnson & Johnson’s DePuy unit testified that months before recalling 93,000 metal-on-metal hip implants, the company phased out the device because of declining sales, not mounting safety concerns.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.